Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

NCT07715734 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Recipient
Cutaneous Squamous Cell Carcinoma (CSCC)
Advanced Cutaneous Squamous Cell Carcinoma
Kidney Transplant

Interventions

DRUG: Cemiplimab
DRUG: Prednisone
DRUG: Sirolimus
DRUG: Cetuximab (EGFR inhibitor)

Sponsor

Washington University School of Medicine

Collaborators

[object Object]